Search Results 511-520 of 11856 for ���������������������������:za33���24������ ������������������������ ������

  1. Clinical trials - Oncology (Medical)

    24, 2024. Share on: FacebookTwitter · Mayo Clinic in Rochester, Minnesota, Mayo Clinic in Jacksonville, Florida, and Mayo Clinic in Phoenix/Scottsdale, Arizona ...

  2. Prostate cancer - Doctors and departments - Mayo Clinic

    Learn about detection, diagnostic approaches, treatment options and advances for prostate cancer, including robotic prostatectomy and current research.

  3. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  4. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  5. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  6. Prostate cancer - Doctors and departments - Mayo Clinic

    Learn about detection, diagnostic approaches, treatment options and advances for prostate cancer, including robotic prostatectomy and current research.

  7. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  8. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  9. A First-in-human Study of 3HP-2827 in Patients With Unresectable or Metastatic Solid Tumors With FGFR2 Alterations - Mayo Clinic

    Rochester, Minnesota: 24-005906; Scottsdale/Phoenix, Arizona: 24-005906. NCT ID: NCT06287918. Sponsor Protocol Number: 3HP-2827-101. About this study. The ...

  10. Phase 2b Study of Investigational Products in Participants with Interstitial Lung Disease Secondary to Systemic Sclerosis - Mayo Clinic

    Progression of ILD (see Note (ii) below) in the previous 24 months; or; FVC < 80% predicted in participants with SSc onset (defined by first non-Raynaud's ...